BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12673842)

  • 1. Prevention of red cell dehydration: a possible new treatment for sickle cell disease.
    Mueller BU; Brugnara C
    Pediatr Pathol Mol Med; 2001; 20(1):15-25. PubMed ID: 12673842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do sickle cells become dehydrated?
    Merciris P; Giraud F
    Hematol J; 2001; 2(3):200-5. PubMed ID: 11920246
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.
    Brugnara C; de Franceschi L; Alper SL
    J Clin Invest; 1993 Jul; 92(1):520-6. PubMed ID: 8326017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies for prevention of sickle cell dehydration.
    Brugnara C
    Blood Cells Mol Dis; 2001; 27(1):71-80. PubMed ID: 11358364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of erythrocyte potassium chloride cotransport, potassium content, and density by dietary magnesium intake in transgenic SAD mouse.
    De Franceschi L; Beuzard Y; Jouault H; Brugnara C
    Blood; 1996 Oct; 88(7):2738-44. PubMed ID: 8839870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.
    De Franceschi L; Bachir D; Galacteros F; Tchernia G; Cynober T; Alper S; Platt O; Beuzard Y; Brugnara C
    J Clin Invest; 1997 Oct; 100(7):1847-52. PubMed ID: 9312186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical trials of new therapeutic pharmacology for sickle cell disease].
    Brugnara C; de Franceschi L
    Sante; 2006; 16(4):263-8. PubMed ID: 17446160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease.
    Brugnara C
    Curr Opin Hematol; 1995 Mar; 2(2):132-8. PubMed ID: 9371983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylcysteine and clotrimazole inhibit sickle erythrocyte dehydration induced by 1-chloro-2,4-dinitrobenzene.
    Shartava A; Shah AK; Goodman SR
    Am J Hematol; 1999 Sep; 62(1):19-24. PubMed ID: 10467272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibitory effects of disodium cromoglycate on ionic transports involved in sickle cell dehydration.
    Bizumukama L; Ferster A; Gulbis B; Kumps A; Cotton F
    Pharmacology; 2009; 83(5):318-22. PubMed ID: 19401631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.
    De Franceschi L; Saadane N; Trudel M; Alper SL; Brugnara C; Beuzard Y
    J Clin Invest; 1994 Apr; 93(4):1670-6. PubMed ID: 7512989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of sickle cell anemia with induced hyponatremia.
    Rosa RM; Bierer BE; Bunn HF; Epstein FH
    Blood Cells; 1982; 8(2):329-35. PubMed ID: 7159756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell disease: from membrane pathophysiology to novel therapies for prevention of erythrocyte dehydration.
    Brugnara C
    J Pediatr Hematol Oncol; 2003 Dec; 25(12):927-33. PubMed ID: 14663274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Established and experimental treatments for sickle cell disease.
    De Franceschi L; Corrocher R
    Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte adhesion is modified by alterations in cellular tonicity and volume.
    Wandersee NJ; Punzalan RC; Rettig MP; Kennedy MD; Pajewski NM; Sabina RL; Paul Scott J; Low PS; Hillery CA
    Br J Haematol; 2005 Nov; 131(3):366-77. PubMed ID: 16225657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of abnormal hemoglobins on the membrane regulation of cell hydration.
    Clark MR; Shohet SB
    Tex Rep Biol Med; 1980-1981; 40():417-29. PubMed ID: 7034277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia.
    Connes P; Machado R; Hue O; Reid H
    Clin Hemorheol Microcirc; 2011; 49(1-4):151-63. PubMed ID: 22214686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal permeability pathways in human red blood cells.
    Ellory JC; Robinson HC; Browning JA; Stewart GW; Gehl KA; Gibson JS
    Blood Cells Mol Dis; 2007; 39(1):1-6. PubMed ID: 17434766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O2 dependence of K+ transport in sickle cells: the effect of different cell populations and the substituted benzaldehyde 12C79.
    Gibson JS; Khan A; Speake PF; Ellory JC
    FASEB J; 2001 Mar; 15(3):823-32. PubMed ID: 11259401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse models of sickle cell disease.
    Beuzard Y
    Transfus Clin Biol; 2008; 15(1-2):7-11. PubMed ID: 18502677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.